Sign up to save your podcasts
Or
Share Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
131 Listeners
Global News Podcast
7,684 Listeners
Neurology® Podcast
287 Listeners
NEJM This Week
323 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Clinical Reviews
496 Listeners
JAMA Neurology Author Interviews
14 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
351 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
363 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
78 Listeners